BMS 300 mg 3622
Generic Name: atazanavir
Pill imprint BMS 300 mg 3622 has been identified as Reyataz 300 mg.
Reyataz is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy.
Reyataz 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Reyataz Images
- Generic Name:
- atazanavir
- Imprint:
-
BMS 300 mg
3622 - Strength:
- 300 mg
- Size:
- 23.00 mm
- Availability:
- Prescription only
- Inactive Ingredients:
- crospovidone
lactose monohydrate
magnesium stearate
gelatin
FD&C Blue No. 2
titanium dioxide
ferric oxide red
ferric oxide yellow
isopropyl alcohol
ammonia
propylene glycol
butyl alcohol
alcohol
ferrosoferric oxide
shellac
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-3622
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-5864 | A S Medication Solutions LLC (repackager) |
| 54868-5838 | Physicians Total Care Inc (repackager) |
| 35356-0114 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Reyataz resources
Search Again
